https://healthsignals.news/afya-yduqs-merger-creates-r9-4bn-brazilian-education-group/ 2026-09-29T20:52:55Z HealthSignals en Afya-Yduqs Merger Creates R$9.4bn Brazilian Education Group 2026-09-29T20:52:55Z Blog https://healthsignals.news/lc-bio-wins-digemid-approval-to-sell-re2o-in-peru/ 2026-09-29T21:09:10Z HealthSignals en L&C Bio Wins Digemid Approval to Sell Re2O in Peru 2026-09-28T17:04:24Z Blog https://healthsignals.news/sanfer-lifts-colombian-drug-capacity-with-more-than-40-million-investment/ 2026-09-29T21:09:10Z HealthSignals en Sanfer Lifts Colombian Drug Capacity With More Than $40 Million Investment 2026-09-28T17:04:18Z Blog https://healthsignals.news/novo-nordisk-faces-generic-pressure-as-chile-spends-nearly-us100m-a-year-on-weight-loss-drugs/ 2026-09-29T21:09:11Z HealthSignals en Novo Nordisk Faces Generic Pressure as Chile Spends Nearly US$100M a Year on Weight-Loss Drugs 2026-09-28T17:04:06Z Blog https://healthsignals.news/bio-techne-shareholders-back-11-3b-merck-kgaa-takeover/ 2026-09-29T21:09:11Z HealthSignals en Bio-Techne Shareholders Back $11.3B Merck KGaA Takeover 2026-09-28T15:14:28Z Blog https://healthsignals.news/telix-to-acquire-itm-in-2-35b-radiopharmaceutical-supply-deal/ 2026-09-29T21:09:11Z HealthSignals en Telix to Acquire ITM in Deal Worth Up to $2.35B 2026-09-28T15:14:24Z Blog https://healthsignals.news/cristalia-readies-phase-1-trial-of-polilaminina-for-spinal-injury/ 2026-09-29T21:09:11Z HealthSignals en Cristália Readies Phase 1 Trial of Polilaminina for Spinal Injury 2026-09-28T15:14:21Z Blog https://healthsignals.news/merck-wins-fda-nod-for-belzutifan-lenvatinib-in-kidney-cancer/ 2026-09-28T22:57:47Z HealthSignals en Merck & Co. Wins FDA Nod for Belzutifan-Lenvatinib in Kidney Cancer 2026-09-28T15:14:17Z Blog https://healthsignals.news/lilly-wins-fda-approval-for-once-weekly-insulin-efsitora/ 2026-09-29T21:09:11Z HealthSignals en Lilly Wins FDA Approval for Once-Weekly Insulin Efsitora 2026-09-28T15:14:14Z Blog https://healthsignals.news/mirum-wins-fda-nod-for-fop-pill-challenging-regeneron/ 2026-09-29T21:09:11Z HealthSignals en Mirum Wins FDA Nod for FOP Pill, Challenging Regeneron 2026-09-28T15:14:10Z Blog https://healthsignals.news/biolab-wins-roche-antiviral-sublicense-for-brazil/ 2026-09-29T21:09:11Z HealthSignals en Biolab Wins Roche Antiviral Sublicense for Brazil 2026-09-28T15:14:03Z Blog https://healthsignals.news/merck-wins-fda-label-update-for-sotatercept-in-early-pah/ 2026-09-29T21:09:11Z HealthSignals en Merck & Co. Wins FDA Label Update for Sotatercept in Recently Diagnosed PAH 2026-09-28T04:17:35Z Blog https://healthsignals.news/meli-enters-prescription-drug-sales-abrafarma-challenges-legality/ 2026-09-29T21:22:33Z HealthSignals en Meli Enters Prescription Drug Sales as Abrafarma Questions Legality 2026-09-28T04:17:32Z Blog https://healthsignals.news/menarini-and-newamsterdam-win-eu-approval-for-obicetrapib/ 2026-09-29T21:22:33Z HealthSignals en Menarini and NewAmsterdam Win EU Approval for Obicetrapib 2026-09-28T04:17:29Z Blog https://healthsignals.news/ultragenyx-wins-fda-nod-for-fayuvi-in-sanfilippo-syndrome/ 2026-09-29T21:22:33Z HealthSignals en Ultragenyx Wins FDA Nod for Fayuvi in Sanfilippo Syndrome 2026-09-28T04:17:25Z Blog https://healthsignals.news/mabxience-and-sandoz-partner-to-commercialize-emicizumab-biosimilar/ 2026-09-29T21:22:33Z HealthSignals en mAbxience and Sandoz Partner to Commercialize Emicizumab Biosimilar 2026-09-28T04:17:22Z Blog https://healthsignals.news/anmat-bans-trifarma-and-ugal-farmaceutica-over-quality-failures/ 2026-09-29T21:22:33Z HealthSignals en ANMAT Preventively Suspends Trifarma and Ugal Farmacéutica 2026-09-28T04:17:18Z Blog https://healthsignals.news/brazils-health-ministry-files-conitec-request-to-add-glp-1-pens-to-sus/ 2026-09-29T21:22:33Z HealthSignals en Brazil's Health Ministry Files Conitec Request to Add GLP-1 Pens to SUS 2026-09-28T04:13:44Z Blog